Budesonide Inhaler Market
- 2026 年市場規模
- USD 8,709 Mn
- 2033 年預估規模
- USD 13,099 Mn
- 年複合成長率 CAGR
- 6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Budesonide Inhaler Market, By Product Type (Inhalants and Nebulizer), By Dosage Form (Aerosols, Dry Powder, Suspension, and Sprays), By Strength (0.25mg, 0.5mg, and 1.0mg), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. For instance, on May 11, 2022, according to the World Health Organization (WHO), Asthma is a major non-communicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children globally. Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths globally. Most asthma-related deaths occur in low- and lower-middle-income countries such as India and Bangladesh, where under-diagnosis and under-treatment is a challenge.
Market Dynamics
The global demand for budesonide inhaler is expected to witness substantial growth over the forecast period, owing to increasing incidences and prevalence of asthma. According to the Global Asthma Report 2018, asthma causes around 1,000 deaths every day and affects as many as 339 million people worldwide.
Increasing product launch by the key market player in expected to boost the growth of global budesonide inhaler market over the forecast period. For instance, in November 2019, Lupin, Pharmaceutical Company, announced the launch of device to track usage pattern of metered-dose inhalers (MDI) by patients suffering from chronic respiratory diseases. The device helped the patients track their metered-dose inhalers (MDI) usage and facilitate improved adherence to therapy. The inhalers are the treatment option for managing chronic respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).
Key features of the study
• This report provides an in-depth analysis of the global budesonide inhaler market, market size (USD Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 – 2030, considering 2021 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global budesonide inhaler market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, Pfizer Inc., Cipla Limited, Lupin Limited, Cosmo Pharmaceuticals, Takeda Pharmaceutical Company Ltd., Manus Aktteva Biopharma LLP, Abbott Laboratories, Lunan Better Pharmaceutical, Novartis International AG (Sandoz), Mylan N.V., Skyepharma, AstraZeneca Plc., Chiesi Farmaceutici S.p.A, Orion Corporation, Santarus Inc., Synmosa Biopharma Corporation, and Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global budesonide inhaler market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global budesonide inhaler market.
Budesonide Inhaler Market Segmentation
• By Product Type Insights (Revenue, USD Mn, 2020 - 2033)
o Inhalants
o Nebulizer
• By Dosage Form Insights (Revenue, USD Mn, 2020 - 2033)
o Aerosols
o Dry Powder
o Suspension
o Sprays
• By Strength Insights (Revenue, USD Mn, 2020 - 2033)
o 0.25mg
o 0.5mg
o 1.0mg
• By Distribution Channel Insights (Revenue, USD Mn, 2020 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, USD Mn, 2020 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o Pfizer Inc.
o Cipla Limited
o Lupin Limited
o Cosmo Pharmaceuticals
o Takeda Pharmaceutical Company Ltd.
o Manus Aktteva Biopharma LLP
o Abbott Laboratories
o Lunan Better Pharmaceutical
o Novartis International AG (Sandoz)
o Mylan N.V.
o Skyepharma
o AstraZeneca Plc.
o Chiesi Farmaceutici S.p.A
o Orion Corporation
o Santarus Inc.
o Synmosa Biopharma Corporation
o Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Dosage Form
Market Snapshot, By Strength
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Regulatory Landscape
o Product Recall
o Epidemiology Analysis
o Technology Overview
o PEST Analysis
o Porter’s Five Forces Model
4. Global Budesonide Inhaler Market, By Product Type, 2026 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Inhalants
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Nebulizers
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
5. Global Budesonide Inhaler Market, By Dosage Form, 2026 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Aerosols
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Dry Powder
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Suspension
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Spray
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Budesonide Inhaler Market, By Strength, 2026 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o 25mg
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o 5mg
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o 0mg
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
7. Global Budesonide Inhaler Market, By Distribution Channel, 2026 – 2033, (USD Mn)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
8. Global Budesonide Inhaler Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026 – 2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Strength, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Strength, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Strength, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn)
o UK
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Strength, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Strength, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Strength, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn)
o North Africa
o Central Africa
o South Africa
9. Competitive Landscape
o Heat Map Analysis
o Company Profile
Pfizer, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cipla Limited
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Lupin Limited
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cosmo Pharmaceuticals
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Takeda Pharmaceutical Company Ltd
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Manus Aktteva Biopharma LLP
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Abbott Laboratories
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Lunan Better Pharmaceutical
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Novartis International AG (Sandoz)
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Mylan N.V.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Skyepharma
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
AstraZeneca Plc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Chiesi Farmaceutici S.p.A.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Orion Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Santarus Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Synmosa Biopharma Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們